Invo BioScience Net Worth 2010-2024 | NAYA

Interactive chart of historical net worth (market cap) for Invo BioScience (NAYA) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. Invo BioScience net worth as of October 22, 2024 is $0B.
Sector Industry Market Cap Revenue
Medical MED-BIOMED/GENE $0.004B $0.003B
INVO Bioscience is a medical device company, headquartered in Beverly, Massachusetts, focused on creating simplified, lower cost treatment options for patients diagnosed with infertility. It engages in the development and manufacture of its lead product, INVOcell, a novel medical device used in infertility treatment that enables egg fertilization and early embryo development in the woman's vaginal cavity. The company was founded by Claude Ranoux, MD, a noted expert in the field of reproductive health, infertility and embryology. INVO Bioscience focuses on selling its product to IVF centers and physicians through distributors, as well as directly to physicians in Europe, Canada, Latin America, and the Middle East.
Stock Name Country Market Cap PE Ratio
Top KingWin (WAI) China $0.007B 0.00
S&W Seed (SANW) United States $0.007B 0.00
Gritstone Bio (GRTSQ) United States $0.000B 0.00